Cargando…

Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract

BACKGROUND: Carcinomas of the renal pelvis and ureter are rare diseases, accounting for only about 1% of all urogenital malignancies. Previous reports suggest that squamous cell histology is associated with inferior survival. We present the largest population based analysis to date of survival in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Berz, David, Rizack, Tina, Weitzen, Sherry, Mega, Anthony, Renzulli, Joseph, Colvin, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256977/
https://www.ncbi.nlm.nih.gov/pubmed/22253551
http://dx.doi.org/10.4137/CMO.S8103
_version_ 1782221085874323456
author Berz, David
Rizack, Tina
Weitzen, Sherry
Mega, Anthony
Renzulli, Joseph
Colvin, Gerald
author_facet Berz, David
Rizack, Tina
Weitzen, Sherry
Mega, Anthony
Renzulli, Joseph
Colvin, Gerald
author_sort Berz, David
collection PubMed
description BACKGROUND: Carcinomas of the renal pelvis and ureter are rare diseases, accounting for only about 1% of all urogenital malignancies. Previous reports suggest that squamous cell histology is associated with inferior survival. We present the largest population based analysis to date of survival in patients with upper urinary tract malignancies. METHODS: We analyzed the Surveillance, Epidemiology and End Results database for cancer specific survival rates in patients with renal pelvis and ureteral malignancies who were diagnosed between 1973 and 2003 in the SEER catchment geographic areas. The primary exposure of interest was the underlying histology, squamous cell versus transitional cell differentiation. We performed descriptive statistics, non parametric survival analysis, and cox proportional hazard analysis. RESULTS: We identified 13,213 eligible patients, 7,716 renal pelvis and 5,497 ureteral carcinomas. Among this cohort, 179 patients had squamous cell carcinoma (SCC), 12,395 had transitional cell carcinoma (TCC), including 121 papillary, and 619 had other histologies. Overall, patients with SCC histology fared worse. The median overall survival time was 10 months for SCC and 63 months for TCC. The cox analysis revealed a HR 3.7 (95% CI 3.0–4.5) for SCC when compared to TCC and corrected for decade of diagnosis, age, gender, prior treatment, and race. The difference between the two groups was entirely attributable to survival differences in patients with loco-regional disease. However, when stratified by lymph node involvement this difference disappeared for patients with locally involved lymph nodes (P = 0.84) and for patients with clear lymph nodes (P = 0.92). CONCLUSIONS: SCCs of the upper urinary tract present at a higher clinical stage and appear to represent more aggressive disease when compared to other histologies. However, when appropriately staged according to lymph node status, the survival of TCC and SCC of the upper urinary tract is identical when compared stage by stage.
format Online
Article
Text
id pubmed-3256977
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-32569772012-01-17 Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract Berz, David Rizack, Tina Weitzen, Sherry Mega, Anthony Renzulli, Joseph Colvin, Gerald Clin Med Insights Oncol Original Research BACKGROUND: Carcinomas of the renal pelvis and ureter are rare diseases, accounting for only about 1% of all urogenital malignancies. Previous reports suggest that squamous cell histology is associated with inferior survival. We present the largest population based analysis to date of survival in patients with upper urinary tract malignancies. METHODS: We analyzed the Surveillance, Epidemiology and End Results database for cancer specific survival rates in patients with renal pelvis and ureteral malignancies who were diagnosed between 1973 and 2003 in the SEER catchment geographic areas. The primary exposure of interest was the underlying histology, squamous cell versus transitional cell differentiation. We performed descriptive statistics, non parametric survival analysis, and cox proportional hazard analysis. RESULTS: We identified 13,213 eligible patients, 7,716 renal pelvis and 5,497 ureteral carcinomas. Among this cohort, 179 patients had squamous cell carcinoma (SCC), 12,395 had transitional cell carcinoma (TCC), including 121 papillary, and 619 had other histologies. Overall, patients with SCC histology fared worse. The median overall survival time was 10 months for SCC and 63 months for TCC. The cox analysis revealed a HR 3.7 (95% CI 3.0–4.5) for SCC when compared to TCC and corrected for decade of diagnosis, age, gender, prior treatment, and race. The difference between the two groups was entirely attributable to survival differences in patients with loco-regional disease. However, when stratified by lymph node involvement this difference disappeared for patients with locally involved lymph nodes (P = 0.84) and for patients with clear lymph nodes (P = 0.92). CONCLUSIONS: SCCs of the upper urinary tract present at a higher clinical stage and appear to represent more aggressive disease when compared to other histologies. However, when appropriately staged according to lymph node status, the survival of TCC and SCC of the upper urinary tract is identical when compared stage by stage. Libertas Academica 2011-12-12 /pmc/articles/PMC3256977/ /pubmed/22253551 http://dx.doi.org/10.4137/CMO.S8103 Text en © the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
spellingShingle Original Research
Berz, David
Rizack, Tina
Weitzen, Sherry
Mega, Anthony
Renzulli, Joseph
Colvin, Gerald
Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
title Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
title_full Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
title_fullStr Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
title_full_unstemmed Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
title_short Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
title_sort survival of patients with squamous cell malignancies of the upper urinary tract
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256977/
https://www.ncbi.nlm.nih.gov/pubmed/22253551
http://dx.doi.org/10.4137/CMO.S8103
work_keys_str_mv AT berzdavid survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract
AT rizacktina survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract
AT weitzensherry survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract
AT megaanthony survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract
AT renzullijoseph survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract
AT colvingerald survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract